EPIVIDIAN Trademark

Trademark Overview


On Monday, May 14, 2012, a trademark application was filed for EPIVIDIAN with the United States Patent and Trademark Office. The USPTO has given the EPIVIDIAN trademark a serial number of 85624595. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, October 3, 2023. This trademark is owned by Epividian, Inc.. The EPIVIDIAN trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

conducting market research via a proprietary database in the medical research field

contract medical research services for others via a proprietary database, namely, conducting pharmacovigilence studies, clinical outcomes assessment, clinical trial protocol feasibility assessment, and clinical trial candidate identification and selection; pharmaceutical information services, namely, clinical data reporting on adverse event reporting systems for pharmaceutical companies; cloud computing featuring software for use by the pharmacovigilance departments of pharmaceutical companies in adverse event management and adverse event signal detection and tracking; providing cloud-based data warehousing and temporary use of non-downloadable software for clinical data reporting and business intelligence for medical records for medical practices and hospital clinics
epividian

General Information


Serial Number85624595
Word MarkEPIVIDIAN
Filing DateMonday, May 14, 2012
Status800 - REGISTERED AND RENEWED
Status DateTuesday, October 3, 2023
Registration Number4316032
Registration DateTuesday, April 9, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 22, 2013

Trademark Statements


Goods and Servicesconducting market research via a proprietary database in the medical research field
Goods and Servicescontract medical research services for others via a proprietary database, namely, conducting pharmacovigilence studies, clinical outcomes assessment, clinical trial protocol feasibility assessment, and clinical trial candidate identification and selection; pharmaceutical information services, namely, clinical data reporting on adverse event reporting systems for pharmaceutical companies; cloud computing featuring software for use by the pharmacovigilance departments of pharmaceutical companies in adverse event management and adverse event signal detection and tracking; providing cloud-based data warehousing and temporary use of non-downloadable software for clinical data reporting and business intelligence for medical records for medical practices and hospital clinics

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, May 18, 2012
Primary Code035
First Use Anywhere DateSunday, May 6, 2012
First Use In Commerce DateSunday, May 6, 2012

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 18, 2012
Primary Code042
First Use Anywhere DateSunday, May 6, 2012
First Use In Commerce DateSunday, May 6, 2012

Trademark Owner History


Party NameEpividian, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Party NameEpividian, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 277092112

Party NameEpividian, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 277092112

Trademark Events


Event DateEvent Description
Tuesday, October 3, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, October 3, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, October 3, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, October 2, 2023TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, September 29, 2023POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Thursday, September 21, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 20, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 20, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 20, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 20, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 15, 2023TEAS SECTION 8 & 9 RECEIVED
Saturday, April 9, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, May 18, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, May 18, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, May 18, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 8, 2019TEAS SECTION 8 & 15 RECEIVED
Friday, February 1, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 9, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 9, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, January 22, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 22, 2013PUBLISHED FOR OPPOSITION
Wednesday, January 2, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 14, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, December 9, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 19, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 19, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 16, 2012ASSIGNED TO LIE
Tuesday, November 6, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 12, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 12, 2012NON-FINAL ACTION E-MAILED
Wednesday, September 12, 2012NON-FINAL ACTION WRITTEN
Wednesday, September 5, 2012ASSIGNED TO EXAMINER
Friday, May 18, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 17, 2012NEW APPLICATION ENTERED